DAXSINIG

What this means for you

Not registered yet, but its 16 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98804013

Mark type

Stylized text

Filed

16 Oct 2024

Published for opposition

24 Dec 2024

Attorney of record

Yana Gorbach

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for treatment of dermatomyositis and lupus

Owner

• Pfizer Inc., New York, NY, US
• Pfizer Inc., New York, NY, US

Prosecution history

• 30 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
• 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 13 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 12 Jan 2026 — SOU EXTENSION 2 GRANTED
• 12 Jan 2026 — SOU EXTENSION 2 FILED
• 12 Jan 2026 — SOU TEAS EXTENSION RECEIVED
• 03 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 03 Jul 2025 — SOU EXTENSION 1 GRANTED
• 02 Jul 2025 — SOU EXTENSION 1 FILED
• 02 Jul 2025 — SOU TEAS EXTENSION RECEIVED
• 18 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 24 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 24 Dec 2024 — PUBLISHED FOR OPPOSITION